Project Grant R21AG089130

Award Date 5/15/25
Completion Date 4/30/27
Dollars Obligated $451K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Dallas, TX 75390, USA
Similar Awards
This federal Project Grant award, funded by the National Institute on Aging (CFDA 93.866 - Aging Research), supports a multi-year, $734,639 research project to investigate age and injury-dependent mechanisms of elastic fiber dynamics in the murine vagina. The primary objectives are to: Determine the cellular sources and regulatory mechanisms of elastic fiber production in the vaginal fibromuscular layer, and how these processes are impacted by age and pelvic floor injury. Elucidate the...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) will provide $574,000.00 in funding to The University of Texas Southwestern Medical Center to conduct research on estrogen-mediated effects on neutrophil function and airway inflammatory response in cystic fibrosis (CF) and non-CF bronchiectasis. The key objectives of this research project are to investigate: (1) the estrogen receptor driving the...
This Project Grant award of $142,000.00 from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports research to investigate the mechanisms underlying sex differences in the emergence of advanced osteoarthritis (OA) pain. The key objectives are to: Determine pathological sprouting of sensory nerves in the knee joint and surrounding muscle of male and female mice with mid-stage and advanced OA pain. This will...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports research on the effects of aging on the function of the muscle protein myosin and its chaperone UNC-45. The $576,893 award, effective September 15, 2024 through May 31, 2029, aims to investigate how age-related post-translational modifications of these proteins contribute to the loss of muscle mass and function, known as sarcopenia, in older adults. The research team, led by the University...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $110,992.00 to the University of California, Davis to conduct research on the role of hypoxia-inducible factor-2a (HIF-2a) signaling in age-induced bone loss. The research aims to establish the relationship between HIF-2a and senescent gene signatures in osteocytes during skeletal aging, demonstrate that osteocyte HIF-2a stabilization drives a senescent gene signature, and determine if HIF-2a...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to The Hospital For Special Surgery Fund, Inc. (doing business as HSS Foundation) provides $688,634 to investigate the mechanisms by which the constitutive interferon-I (IFN-I) response suppresses osteoblastogenesis and impacts bone homeostasis. The award aims to elucidate how the effects of the constitutive IFN-I response in osteoblasts and osteocytes are influenced by aging in both males and females,...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $206,023 to Cornell University to investigate the effects of mechanical stress on cell behavior in injured cartilage. The research aims to develop a framework for analyzing the spatiotemporal response of cells to cartilage injury, with a focus on understanding the role of calcium...
This federal Project Grant award, with ID R01AG086058, was provided by the National Institute on Aging (CFDA 93.866 - Aging Research) to New York University School of Medicine. The $1,905,716.00 grant, awarded on August 1, 2024, will support a 5-year research project to investigate the molecular mechanisms regulating the inflammatory response in skeletal stem and progenitor cells, and the role of anti-inflammatory factors in resolving inflammation. The project aims to generate insights into...
This $884,888 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports research at Brigham & Women's Hospital to investigate the molecular mechanisms by which sex hormones, particularly testosterone and estradiol, modulate wound healing. The key objectives of this 18-month research project are to: 1) develop improved in vitro models to study how sex hormones affect wound cell behavior; 2)...
This federal Project Grant award of $147,656 from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research, will fund research at Stanford University to explore the biophysical mechanisms by which mechanical loading enhances cartilage formation in chondrocytes. The research aims to: 1) Examine how anabolic loading conditions are influenced by the viscoelastic properties of the extracellular matrix,...

This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $451,000.00 to The University of Texas Southwestern Medical Center to investigate how the sex hormone estrogen modulates the mechanotransduction response of chondrocytes (cartilage cells) via the ion channels Piezo1 and TRPV4. The goal is to better understand the sex-specific differences in cartilage degeneration and the influence of hormonal changes, particularly in women undergoing menopause. The research will isolate chondrocytes from healthy human cartilage and examine the effects of estrogen on calcium signaling, gene expression, and cartilage anabolic/catabolic markers in response to mechanical stimulation. This work aims to identify new targets for treating and preventing age-related cartilage degeneration, with a focus on understanding how sex hormones impact cartilage health in both cisgender and transgender populations. The award period runs from May 2025 through April 2027.

Generated 6/17/25, 4:06 AM